InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: dangerM post# 44931

Saturday, 06/30/2018 8:44:36 PM

Saturday, June 30, 2018 8:44:36 PM

Post# of 48316
You are correct dangerM. That is the same reposted article from Nature. I must have had a brain lapse. The direction that Oncosec is headed sounds exactly where this article is pointing to. Oncosec market disruption coming in the near future. Time for the market to wake up to Oncosec. We are building up to it in the second half of this year. The updates listed the other day are very reassuring that things will start to move along at a quicker pace.

Merck partnering in Head and Neck will be their 3rd collaboration agreement with Oncosec.
Bristol Myers' Opdivo in combo with Oncosec in neoadjuvant melanoma means they are getting on board as well finally.....a very good sign.

The multi-gene construct to be announced soon will utilize the latest Oncosec generator and applicators and hopefully take the market by surprise.

Oncosec is setting up for a very strong end of year with PISCES data to be released in the fall. If the results are stellar like the SITC results last year, 2019 will be explosive for the company. Multiple licensing deals will be struck. Oncosec will increase significantly in market cap and hopefully entertain a buyout offer.